Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study

Roberto Lozano‐Rodríguez, Verónica Terrón‐Arcos, Karla Montalbán‐Hernández, José Carlos Casalvilla‐Dueñas, Marta Bergón‐Gutierrez, Alejandro Pascual‐Iglesias, Jaime Valentín Quiroga, Luis A. Aguirre, Rebeca Pérez de Diego, Carmen Vela‐Olmo, Lissette López‐Morejón, Alejandro Martín‐Quirós, Álvaro del Balzo‐Castillo, María A. Peinado‐Quesada, Miguel A. García‐Garrido, Laura Gómez‐Lage, Carmen Herrero‐Benito, Irene Llorente‐Fernández, Gema Martín‐Miguel, Margarita Torrejón, Carolina Cubillos‐Zapata, Carlos del Fresno, José Avendaño‐Ortiz, Eduardo López‐Collazo

Open source

DOI
10.1002/ctm2.869
Published
2022-05
Container
Clinical and Translational Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.869,
  title = {Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study},
  author = {Roberto Lozano‐Rodríguez and Verónica Terrón‐Arcos and Karla Montalbán‐Hernández and José Carlos Casalvilla‐Dueñas and Marta Bergón‐Gutierrez and Alejandro Pascual‐Iglesias and Jaime Valentín Quiroga and Luis A. Aguirre and Rebeca Pérez de Diego and Carmen Vela‐Olmo and Lissette López‐Morejón and Alejandro Martín‐Quirós and Álvaro del Balzo‐Castillo and María A. Peinado‐Quesada and Miguel A. García‐Garrido and Laura Gómez‐Lage and Carmen Herrero‐Benito and Irene Llorente‐Fernández and Gema Martín‐Miguel and Margarita Torrejón and Carolina Cubillos‐Zapata and Carlos del Fresno and José Avendaño‐Ortiz and Eduardo López‐Collazo},
  year = {2022},
  journal = {Clinical and Translational Medicine},
  doi = {10.1002/ctm2.869},
  url = {https://doi.org/10.1002/ctm2.869}
}

RIS

TY  - JOUR
TI  - Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
AU  - Roberto Lozano‐Rodríguez
AU  - Verónica Terrón‐Arcos
AU  - Karla Montalbán‐Hernández
AU  - José Carlos Casalvilla‐Dueñas
AU  - Marta Bergón‐Gutierrez
AU  - Alejandro Pascual‐Iglesias
AU  - Jaime Valentín Quiroga
AU  - Luis A. Aguirre
AU  - Rebeca Pérez de Diego
AU  - Carmen Vela‐Olmo
AU  - Lissette López‐Morejón
AU  - Alejandro Martín‐Quirós
AU  - Álvaro del Balzo‐Castillo
AU  - María A. Peinado‐Quesada
AU  - Miguel A. García‐Garrido
AU  - Laura Gómez‐Lage
AU  - Carmen Herrero‐Benito
AU  - Irene Llorente‐Fernández
AU  - Gema Martín‐Miguel
AU  - Margarita Torrejón
AU  - Carolina Cubillos‐Zapata
AU  - Carlos del Fresno
AU  - José Avendaño‐Ortiz
AU  - Eduardo López‐Collazo
PY  - 2022
JO  - Clinical and Translational Medicine
DO  - 10.1002/ctm2.869
UR  - https://doi.org/10.1002/ctm2.869
ER  - 

APA

Lozano‐Rodríguez, R., Terrón‐Arcos, V., Montalbán‐Hernández, K., Casalvilla‐Dueñas, J. C., Bergón‐Gutierrez, M., Pascual‐Iglesias, A., Quiroga, J. V., Aguirre, L. A., Diego, R. P. D., Vela‐Olmo, C., López‐Morejón, L., Martín‐Quirós, A., Balzo‐Castillo, Á. D., Peinado‐Quesada, M. A., García‐Garrido, M. A., Gómez‐Lage, L., Herrero‐Benito, C., Llorente‐Fernández, I., Martín‐Miguel, G., Torrejón, M., Cubillos‐Zapata, C., Fresno, C. D., Avendaño‐Ortiz, J., & López‐Collazo, E. (2022). Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.869

Source records